Fabtech Technologies Limited (FABTECH) reports Q1 FY27 with 10% revenue growth, turning a net profit of ₹4.21 crores.
Laurus Labs Limited (NSE: LAURUSLABS) announces Q1 FY27 results with 29% revenue growth, ₹644 Cr EBITDA, and 31.8% EBITDA margins.
Dr. Lal Path Labs Ltd. (LALPATHLAB) reports a 19.1% revenue growth and 27.2% PAT increase in Q1 FY27.
Thyrocare Technologies Limited (THYROCARE) stock breaks out, gaining 7% intraday to ₹588.6, backed by strong Q1FY27 results..
Sun Pharma reports Organon shareholder approval for acquisition, marking a significant step towards completing the merger transaction.
Thyrocare Technologies Limited (THYROCARE) reports Q1FY27 results with a 24% YoY revenue growth and a 34% YoY PAT increase.
Solara Active Pharma Sciences Limited (SOLARA) reports Q1’27 earnings with base business revenues up 24% YoY, EBITDA up 8% despite geopolitical impacts.
Cipla Limited (CIPLA) achieves highest-ever quarterly revenue of INR 7,119 Cr in Q1FY27, driven by strong market performance.
Zydus Lifesciences Limited (ZYDUSLIFE) gets approval for Phase III trial of Desidustat for sickle cell disease patients.
Rubicon Research Limited (NSE: RUBICON) acquires its first US manufacturing facility in East Brunswick, NJ for USD 2.9 million.